Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Videourodynamics in patients with neurogenic bladder due to multiple sclerosis: our experience.

Caramella D, Donatelli G, Armillotta N, Manassero F, Traversi C, Frumento P, Pistolesi D, Selli C.

Radiol Med. 2011 Apr;116(3):432-43. doi: 10.1007/s11547-011-0620-2. Epub 2011 Jan 12. English, Italian.

PMID:
21225364
2.

Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment.

Alloussi SH, Lang Ch, Eichel R, Al-Kaabneh A, Seibold J, Schwentner C, Alloussi S.

World J Urol. 2012 Jun;30(3):367-73. doi: 10.1007/s00345-011-0736-6. Epub 2011 Aug 13.

PMID:
21842216
3.

Endoscopic treatment of vesicoureteral reflux with non-simultaneous involuntary detrusor contraction in chronic spinal cord injury patients with neurogenic detrusor overactivity.

Vírseda MC, Salinas JC, Bolufer E, Esteban MF.

Urol Int. 2014;93(4):399-402. doi: 10.1159/000357440. Epub 2014 Mar 12.

PMID:
24642572
4.

Videourodynamics in the diagnosis of urinary tract abnormalities in a single center.

Szabó L, Lombay B, Borbás E, Bajusz I.

Pediatr Nephrol. 2004 Mar;19(3):326-31. Epub 2003 Dec 20.

PMID:
14689290
5.

Vesico-ureteral reflux in children with spina bifida and detrusor-sphincter dyssynergia.

van Gool JD.

Contrib Nephrol. 1984;39:221-37. No abstract available.

PMID:
6744873
6.

OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.

Rovner E, Dmochowski R, Chapple C, Thompson C, Lam W, Haag-Molkenteller C.

Neurourol Urodyn. 2013 Nov;32(8):1109-15. doi: 10.1002/nau.22376. Epub 2013 Feb 6.

7.
8.

Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.

Giannantoni A, Mearini E, Del Zingaro M, Porena M.

Eur Urol. 2009 Mar;55(3):705-11. doi: 10.1016/j.eururo.2008.08.048. Epub 2008 Sep 2.

PMID:
18814955
9.

[Urodynamic findings in patients with infantile cerebral palsy].

Bross S, Pomer S, Döderlein L, Knoll T, Michel MS, Staehler G, Gerner HJ, Alken P.

Aktuelle Urol. 2004 Feb;35(1):54-7. German.

PMID:
14997416
10.

Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.

Chen G, Liao L.

Int Urol Nephrol. 2011 Sep;43(3):655-62. doi: 10.1007/s11255-010-9873-x. Epub 2010 Nov 26.

PMID:
21110094
11.

Pseudoreflux and detrusor overactivity due to accidental ureteral catheterization during cytometry in a pediatric patient.

Wolff GF, Smith PP.

J Pediatr Urol. 2013 Feb;9(1):e68-71. doi: 10.1016/j.jpurol.2012.08.010. Epub 2012 Sep 27.

PMID:
23022154
13.

Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany.

Wefer B, Ehlken B, Bremer J, Burgdörfer H, Domurath B, Hampel C, Kutzenberger J, Seif C, Sievert KD, Berger K, Pannek J.

World J Urol. 2010 Jun;28(3):385-90. doi: 10.1007/s00345-009-0466-1. Epub 2009 Aug 20.

PMID:
19693509
14.

Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury.

Silva JA, Gonsalves Mde C, de Melo RT, Carrerette FB, Damião R.

World J Urol. 2015 Jan;33(1):131-5. doi: 10.1007/s00345-014-1265-x. Epub 2014 Feb 27.

PMID:
24573904
15.

Urodynamic study in the neurogenic bladder dysfunction caused by intervertebral disk hernia.

Dong D, Xu Z, Shi B, Chen J, Jiang X, Wang H.

Neurourol Urodyn. 2006;25(5):446-50.

PMID:
16847921
16.

[Video-urodynamic studies on 1800 patients with neurogenic bladder].

JU YH, LIAO LM, LI D, FU G, LIANG WL, XIONG ZS, WU J, SHI WB, HAN CS.

Zhonghua Wai Ke Za Zhi. 2008 Oct 15;46(20):1525-8. Chinese.

PMID:
19094643
17.

Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.

Gobeaux N, Yates DR, Denys P, Even-Schneider A, Richard F, Chartier-Kastler E.

Neurourol Urodyn. 2012 Jun;31(5):672-6. doi: 10.1002/nau.21239. Epub 2012 Apr 24.

PMID:
22532256
18.

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.

Ginsberg D, Cruz F, Herschorn S, Gousse A, Keppenne V, Aliotta P, Sievert KD, Brin MF, Jenkins B, Thompson C, Lam W, Heesakkers J, Haag-Molkenteller C.

Adv Ther. 2013 Sep;30(9):819-33. doi: 10.1007/s12325-013-0054-z. Epub 2013 Sep 27. Erratum in: Adv Ther. 2014 Feb;31(2):242.

19.

Augmentation enterocystoplasty without reimplantation for patients with neurogenic bladder and vesicoureteral reflux.

Zhang HC, Yang J, Ye X, Hu HF.

Kaohsiung J Med Sci. 2016 Jun;32(6):323-6. doi: 10.1016/j.kjms.2016.05.003. Epub 2016 Jun 27.

20.

Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction.

Van Batavia JP, Ahn JJ, Fast AM, Combs AJ, Glassberg KI.

J Urol. 2013 Oct;190(4 Suppl):1495-9. doi: 10.1016/j.juro.2013.02.016. Epub 2013 Feb 14.

PMID:
23416636

Supplemental Content

Support Center